Immunophenotyping and Activation Status of Maternal Lymphocytes to Predict Spontaneous Preterm Birth in Women With Threatened Preterm Labor: A Prospective Observational Study

• Published in: American journal of reproductive immunology (1989) 2024-12, Vol.92 (6), p.e70015
• Main Authors: Wendremaire, Maeva, Hadi, Tarik, Lopez, Tatiana E, Guy, Julien, Neiers, Fabrice, Garrido, Carmen, Simon, Emmanuel, Jaffal, Zohra, Bernigal, Virginie, Bardou, Marc, Lirussi, Frédéric
• Format: Article
• Language: English
• Subjects: Adult; Female; HLA-DR Antigens - immunology; HLA-DR Antigens - metabolism; Humans; Immunology; Immunophenotyping; Life Sciences; Lymphocyte Activation - immunology; Obstetric Labor, Premature - immunology; Original; Pregnancy; Premature Birth - immunology; Prospective Studies; Young Adult
• ISSN: 1600-0897; 1046-7408; 1600-0897
• DOI: 10.1111/aji.70015

Preterm birth (PTB) remains the leading cause of neonatal morbidity and mortality. Identifying women at high risk of spontaneous preterm labor (PTL) is challenging due to limited efficient diagnostic markers. Since human parturition involves inflammatory immune processes, we hypothesized that phenotyping of maternal peripheral lymphocytes might predict PTL. Therefore, we aimed to explore the relationship between maternal lymphocyte subpopulations and labor onset characterized by delivery within 7 days of admission in women hospitalized for PTL between 24 and 34 weeks of gestation. Lymphocyte subpopulations were obtained from peripheral blood samples and characterized by flow cytometry: activated and regulatory T cells, natural killer and B cells, and T 1/T 2/T 17 lymphocytes. Data analysis was conducted retrospectively based on the delivery within 7 days of admission. Among 167 women admitted for PTL, less than 10% delivered within 7 days post-admission. HLA-DR expression was significantly increased on CD4 CD8 , CD4 CD8 , and CD4 CD8 lymphocytes in women who delivered within 7 days. Subset levels below 5% of CD4 CD8 HLA-DR lymphocytes and 20% of CD4 CD8 HLA-DR lymphocytes were associated with no probability of delivering within 7 days. Our study suggests that combining these two consecutive markers allowed us to identify 57% of women hospitalized for PTL with no probability of delivering within 7 days while retaining patients who delivered within 7 days. If prospectively validated, these markers may be able to identify patients at high risk of PTB and avoid a significant number of unnecessary admissions and healthcare costs. ANSM number: 2010-A00516-33; ClinicalTrials.gov identifier: NCT01340222.